Gill, Hartej

Impact of COVID-19 pandemic on mental health in the general population: a systematic review

Xiong, J., Lipsitz, O., Nasri, F., Lui, L. M. W., Gill, H., Phan, L., Chen-Li, D., Iacobucci, M., Ho, R., Majeed, A., et al. (2020) · Journal of Affective Disorders

COVID-19 and Mental HealthMaternal Mental Health During Pregnancy and Postpartum

Cited by 5,204

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis

Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 1,554

The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis

Park, C., Majeed, A., Gill, H., Tamura, J., Ho, R. C., Mansur, R. B., Nasri, F., Lee, Y., Rosenblat, J. D., Wong, E., et al. (2020) · Psychiatry Research

Health disparities and outcomesCOVID-19 and Mental Health

Cited by 604

The Long-Term Effect of Bariatric Surgery on Depression and Anxiety

Gill, H., Kang, S., Lee, Y., Rosenblat, J. D., Brietzke, E., Zuckerman, H., & McIntyre, R. S. (2019) · Journal of Affective Disorders

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 191

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

McIntyre, R. S., Carvalho, I. P., Lui, L. M. W., Majeed, A., Masand, P. S., Gill, H., Rodrigues, N. B., Lipsitz, O., Coles, A. C., Lee, Y., et al. (2020) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 187

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

Alnefeesi, Y., Chen-Li, D., Krane, E., Jawad, M. Y., Rodrigues, N. B., Ceban, F., Di Vincenzo, J. D., Meshkat, S., Ho, R. C. M., Gill, H., et al. (2022) · Journal of Psychiatric Research

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 186

Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression

Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 127

The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis

Xiong, J., Lipsitz, O., Chen-Li, D., Rosenblat, J. D., Rodrigues, N. B., Carvalho, I., Lui, L. M. W., Gill, H., Narsi, F., Mansur, R. B., et al. (2021) · Journal of Psychiatric Research

Treatment of Major DepressionSuicide and Self-Harm Studies

Cited by 124

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence

McIntyre, R. S., Rodrigues, N. B., Lee, Y., Lipsitz, O., Subramaniapillai, M., Gill, H., Nasri, F., Majeed, A., Lui, L. M. W., Senyk, O., et al. (2020) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 110

Registered clinical studies investigating psychedelic drugs for psychiatric disorders

Siegel, A. N., Meshkat, S., Benitah, K., Lipsitz, O., Gill, H., Lui, L. M. W., Teopiz, K. M., McIntyre, R. S., & Rosenblat, J. D. (2021) · Journal of Psychiatric Research

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 97

The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research

Gill, H., Gill, B., Rodrigues, N. B., Lipsitz, O., Rosenblat, J. D., El-Halabi, S., Nasri, F., Mansur, R. B., Lee, Y., & McIntyre, R. S. (2021) · Neuroscience & Biobehavioral Reviews

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 93

Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review

Badulescu, S., Tabassum, A., Le, G. H., Wong, S., Phan, L., Gill, H., Llach, C.-D., McIntyre, R. S., Rosenblat, J., & Mansur, R. (2024) · Physiology & Behavior

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 90

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review

Cooper, D. H., Ramachandra, R., Ceban, F., Di Vincenzo, J. D., Rhee, T. G., Mansur, R. B., Teopiz, K. M., Gill, H., Ho, R., Cao, B., et al. (2023) · Journal of Psychiatric Research

Diabetes Treatment and ManagementTreatment of Major Depression

Cited by 79

Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review

Siegel, A. N., Di Vincenzo, J. D., Brietzke, E., Gill, H., Rodrigues, N. B., Lui, L. M. W., Teopiz, K. M., Ng, J., Ho, R., McIntyre, R. S., et al. (2021) · Journal of Psychiatric Research

Treatment of Major DepressionSuicide and Self-Harm Studies

Cited by 70

The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder

McIntyre, R. S., Lipsitz, O., Rodrigues, N. B., Lee, Y., Cha, D. S., Vinberg, M., Lin, K., Malhi, G. S., Subramaniapillai, M., Kratiuk, K., et al. (2020) · Bipolar Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 66

Development and implementation of guidelines for the management of depression: a systematic review

Lee, Y., Brietzke, E., Cao, B., Chen, Y., Linnaranta, O., Mansur, R. B., Cortes, P., Kösters, M., Majeed, A., Tamura, J. K., et al. (2020) · Bulletin of the World Health Organization

Clinical practice guidelines implementationMental Health Treatment and Access

Cited by 45

Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression

Fancy, F., Rodrigues, N. B., Di Vincenzo, J. D., Chau, E. H., Sethi, R., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., et al. (2023) · Bipolar Disorders

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 40

Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review

Le, G. H., Wong, S., Badulescu, S., Au, H., Di Vincenzo, J. D., Gill, H., Phan, L., Rhee, T. G., Ho, R., Teopiz, K. M., et al. (2024) · Journal of Affective Disorders

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 30

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., et al. (2023) · Journal of Psychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 23

The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine

McIntyre, R. S., Lipsitz, O., Lui, L. M. W., Rodrigues, N. B., Gill, H., Nasri, F., Ling, R., Teopiz, K. M., Ho, R. C., Subramaniapillai, M., et al. (2021) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 21

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

McIntyre, R. S., Rodrigues, N. B., Lipsitz, O., Nasri, F., Gill, H., Lui, L. M., Subramaniapillai, M., Kratiuk, K., Teopiz, K., Ho, R., et al. (2021) · Journal of Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 20

Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

Rodrigues, N. B., Siegel, A., Lipsitz, O., Cha, D. S., Gill, H., Nasri, F., Simonson, K., Shekotikhina, M., Lee, Y., Subramaniapillai, M., et al. (2022) · CNS Spectrums

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 17

The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies

Gill, H., Puramat, P., Patel, P., Gill, B., Marks, C. A., Rodrigues, N. B., Castle, D., Cha, D. S., Mansur, R. B., Rosenblat, J. D., et al. (2022) · Psychiatry Research

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 16

Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence

Di Vincenzo, J. D., Lipsitz, O., Rodrigues, N. B., Lee, Y., Gill, H., Kratiuk, K., Subramaniapillai, M., Mansur, R., McIntyre, R. S., & Rosenblat, J. D. (2021) · Journal of Psychiatric Research

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 12